At Med Communications, we recognize that dependable vendor support is essential for our clients. Our remote-first, adaptable business model ensures continuity even in the face of unexpected challenges, including severe…
Med Communications offers a boutique pharmacovigilance experience with global reach, combining personalized attention with international regulatory expertise. Seamless integration of pharmacovigilance and medical information improves workflow efficiency. Our clients appreciate…
Med Communications delivers end-to-end pharmacovigilance services built for today’s global, technology-driven safety landscape. Our capabilities span the full lifecycle of PV operations: Our team of highly skilled pharmacovigilance professionals is…
Maria Anitan, MD, is Global Head of Pharmacovigilance at Med Communications. Maria is an experienced pharmaceutical industry professional with more than 15 years in leadership roles covering pharmacovigilance, medical affairs,…
As our American colleagues and clients prepare to celebrate Thanksgiving this Thursday, we wanted to give thanks to each of you. We appreciate your trust and your support — we…
Infographics are often used in reactive or proactive documents by Medical Affairs personnel during face-to-face interactions with healthcare professionals (HCPs). They are also used in medical information documents such as…
Med Communications’ newest service area, Regulatory Writing, offers support across all stages of clinical drug development: Under the leadership of department director Ann Winter-Vann, who has more than 18 years…
Our newest department, Regulatory Writing, is led by Dr. Ann Winter-Vann. Ann received her PhD in Molecular Cancer Biology from Duke University, where she was supported by a fellowship from…
Med Communications’ Ann Winter-Vann, director of Regulatory Writing, and Jill Kembel, Business Development Lead, are at the AMWA conference in Phoenix, Arizona, this week. Ann is presenting a sold-out workshop…
Med Communications is at the World Drug Safety Congress Americas in Boston this week. Our Global Head of Pharmacovigilance and Drug Safety, Dr. Maria Anitan, will be participating in a…
